BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10129683)

  • 21. Quality of life and prostate cancer treatment: decision-making and rehabilitative support.
    Ritvo PG
    Can J Oncol; 1994 Nov; 4 Suppl 1():43-5; discussion 46. PubMed ID: 8853489
    [No Abstract]   [Full Text] [Related]  

  • 22. The information needed by Canadian early-stage prostate cancer patients for decision-making: stable over a decade.
    Feldman-Stewart D; Brennenstuhl S; Brundage MD
    Patient Educ Couns; 2008 Dec; 73(3):437-42. PubMed ID: 18762405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer screening: why it's not for every man.
    Lakhan SE
    Medscape J Med; 2008; 10(8):182; author reply 182. PubMed ID: 18924634
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel computer based expert decision making model for prostate cancer disease management.
    Richman MB; Forman EH; Bayazit Y; Einstein DB; Resnick MI; Stovsky MD
    J Urol; 2005 Dec; 174(6):2310-8. PubMed ID: 16280831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New trial data do not end the PSA screening debate.
    Vastag B
    J Natl Cancer Inst; 2009 Jun; 101(12):844-5. PubMed ID: 19509364
    [No Abstract]   [Full Text] [Related]  

  • 26. [Controversial guidelines in early diagnosis of prostate cancer].
    Casal ER; Majdalani MP
    Medicina (B Aires); 2003; 63(1):77-81. PubMed ID: 12673967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health information styles among participants in a prostate cancer screening informed decision-making intervention.
    Williams-Piehota PA; McCormack LA; Treiman K; Bann CM
    Health Educ Res; 2008 Jun; 23(3):440-53. PubMed ID: 18385197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer patients blindsided by side effects.
    J Oncol Manag; 2000; 9(4):10-2. PubMed ID: 11186506
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
    Davison BJ; Goldenberg SL; Gleave ME; Degner LF
    Oncol Nurs Forum; 2003; 30(1):107-14. PubMed ID: 12515988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic conditions and marriage quality of men with prostate cancer.
    Sunny L; Hopfgarten T; Adolfsson J; Steineck G
    BJU Int; 2007 Jun; 99(6):1391-7. PubMed ID: 17355370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtually he@lthy: the impact of internet use on disease experience and the doctor-patient relationship.
    Broom A
    Qual Health Res; 2005 Mar; 15(3):325-45. PubMed ID: 15761103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The patient, actor of his route to health].
    Cormier L
    Rev Infirm; 2010 Mar; (158):21-4. PubMed ID: 20383951
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluating a decision aid for patients with localized prostate cancer in clinical practice.
    Isebaert S; Van Audenhove C; Haustermans K; Junius S; Joniau S; De Ridder K; Van Poppel H
    Urol Int; 2008; 81(4):383-8. PubMed ID: 19077396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of a web-based prostate cancer decision site.
    Moul JW; Esther TA; Bauer JJ
    Semin Urol Oncol; 2000 Aug; 18(3):241-4. PubMed ID: 10975497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Communicating effectively with the patient and family about treatment options for prostate cancer.
    Kunkel EJ; Myers RE; Lartey PL; Oyesanmi O
    Semin Urol Oncol; 2000 Aug; 18(3):233-40. PubMed ID: 10975496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The participation experiences of localized prostate cancer patients in the treatment decision-making process].
    Chien CH; Chuang CK; Liu KL; Liu HE
    Hu Li Za Zhi; 2007 Feb; 54(1):35-42. PubMed ID: 17340546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.
    Farrell MH; Murphy MA; Schneider CE
    Eff Clin Pract; 2002; 5(3):120-9. PubMed ID: 12088291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.